Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

被引：0
作者：
Ketan Sheth
Rohit Borker
Amanda Emmett
Kathleen Rickard
Paul Dorinsky
机构：
[1] Allergy/Asthma Section,
[2] Arnett Clinic,undefined
[3] GlaxoSmithKline Inc.,undefined
来源：
PharmacoEconomics | 2002年 / 20卷
关键词：
Fluticasone Propionate; Salmeterol; Montelukast; Persistent Asthma; Propionate Group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To compare the relative cost effectiveness of salmeterol (50μg)/ fluticasone propionate (100μg) with that of oral montelukast (10mg) as initial maintenance therapy in patients with persistent asthma uncontrolled on short-acting β2-agonist therapy alone.
引用
收藏
页码：909 / 918
页数：9
相关论文
共 43 条
[31]  
Kielhorn A(undefined)undefined undefined undefined undefined-undefined
[32]  
Weber HH(undefined)undefined undefined undefined undefined-undefined
[33]  
Lord J(undefined)undefined undefined undefined undefined-undefined
[34]  
Asante M(undefined)undefined undefined undefined undefined-undefined
[35]  
Pearlman D(undefined)undefined undefined undefined undefined-undefined
[36]  
White M(undefined)undefined undefined undefined undefined-undefined
[37]  
Lieberman A(undefined)undefined undefined undefined undefined-undefined
[38]  
Stempel D(undefined)undefined undefined undefined undefined-undefined
[39]  
O’Donnell J(undefined)undefined undefined undefined undefined-undefined
[40]  
Myer J(undefined)undefined undefined undefined undefined-undefined
12345